-- 周一下午晚些时候,科技股涨跌互现,道富科技精选行业SPDR ETF (XLK)上涨0.3%,道富SPDR标普半导体ETF (XSD)下跌0.1%。 费城半导体指数下跌0.2%。 公司新闻方面,据彭博社报道,苹果公司(AAPL)计划在其下一次iPhone软件更新中推出一项新功能,允许用户在“钱包”应用中创建和个性化自己的电子票券和礼品卡。报道称,iOS 27“钱包”应用的这项通行证创建功能有望解决许多服务仍无法提供与“钱包”平台兼容的通行证的问题。苹果股价下跌1.3%。 据彭博社报道,微软(MSFT)支持的OpenAI已从投资者处获得超过40亿美元的资金,用于成立一家价值100亿美元的新合资企业,以扩大其人工智能产品的应用。微软股价下跌0.5%。 思科系统公司 (CSCO) 股价上涨 0.8%,此前该公司周一宣布计划收购 Astrix Security,以扩展其自动化代理和非人类身份防御能力。 Blaize (BZAI) 宣布与 Winmate 签署战略合作协议,将其人工智能芯片集成到国防和关键基础设施系统中,预计第一年业务收入约为 1500 万美元。Blaize 股价飙升 20%。
Related Articles
Westpac's Total Capital, CET1 Capital Up Year on Year in March Quarter
Westpac Banking (ASX:WBC, NZE:WBC) total capital and Common Equity Tier 1 (CET1) capital both increased year-over-year in the March quarter, according to a Tuesday Australian bourse filing.The bank's total capital in the three months to March came in at AU$98.54 billion, up from the AU$97.14 billion it reported in the year-ago period. Its CET1 capital for the period clocked in at AU$56.94 billion, rising from the AU$55.01 billion it reported for the March 2025 quarter.Its CET1 ratio for the March quarter was 12.4%, compared with a ratio of 12.2% in the prior-year period. It reported a liquidity coverage ratio of 132% for the quarter, compared with 135% in the same period in the previous year.
Research Alert: CFRA Raises Opinion On Shares Of Gildan Activewear To Buy From Hold
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our 12-month price target of CAD98, based on 16.0x our 2026 EPS estimate and above the company's five-year average forward P/E multiple of 12.9x, reflecting our view that the company deserves an above-peer multiple. We view the recent acquisition of HanesBrands as positive and believe the company will improve Hanes' operating efficiency while capitalizing on significant synergies. GIL reported Q1 2026 results that reflect the significant impact of its HanesBrands acquisition, with revenues increasing 64% to $1.17B, $18M above estimates, while facing substantial integration-related charges. Adjusted EPS from continuing operations declined to $0.43 from $0.59, $0.08 above consensus estimates, reflecting higher share count from the acquisition and ongoing integration expenses. We now view shares more positively after a 20% decline from its 52-week high just a few months ago. Shares currently trade at 13.5x the midpoint of the company's full-year EPS guidance.
Medibank Private Reports Policyholder Growth in Nine Months to March 31, Maintains Outlook
Medibank Private (ASX:MPL) reported policyholder growth of 22,400 in its resident private health insurance business in the nine months to March 31, up 25% from the same period a year earlier, according to a Tuesday filing with the Australian bourse.The company said the resident private health insurance industry has become more competitive in recent months, with data showing consumers increasingly prioritizing value and some participants resorting to price-led customer propositions."While no new material trends have emerged in 2026, Medibank will continue to monitor utilization given historic behavior and competitor activity as we remain disciplined," it said.Medibank maintained its fiscal 2026 guidance, saying it does not expect global events and volatility to have a direct impact on its businesses.The company's main financial exposure is through its investment portfolio, which includes about AU$188 million of investments in equities, and through movements in Australia's cash rate where it flagged a roughly AU$7 million annual impact to investment income.